Key result
Post-COVID-19 hypertension prevalence among US adults remains unchanged from pre-pandemic levels.
Why the study?
Hypertension is a leading cause of death and disability in the US, but national trends following the COVID-19 pandemic remained unknown.
Did hypertension prevalence, awareness, and control change in US adults after the COVID-19 pandemic?
Cross-Sectional (n=14,449)
Yes
Did hypertension prevalence, awareness, and control change in US adults after the COVID-19 pandemic?
Hypertension prevalence, awareness, and control in the US remained poor and unchanged after the COVID-19 pandemic, with control worsening in men and awareness declining in younger adults.
Answers are grounded in this paper and cite their sources.
No post-pandemic gains in hypertension prevalence or control; leaves open whether targeted efforts can reverse stagnation in young adults and men.
Hypertension is a leading cause of death and disability in the United States, but national trends in hypertension after the COVID-19 pandemic remain unknown. We analyzed NHANES data from pre-pandemic (2017-March 2020) and post-pandemic (August 2021-August 2023) surveys to determine nationwide prevalence, awareness, and control of hypertension. Weighted, age-standardized prevalence estimates were compared using Poisson regression with prevalence ratios (PRs). Among 14 449 participants representing 237 million US adults, hypertension prevalence was 49.5% pre-pandemic versus 47.7% post-pandemic (PR 0.96; p = 0.15). Overall, hypertension awareness was unchanged (57.7% vs. 53.7%; PR 0.96; p = 0.14) but declined among adults aged 18-39 years (PR 0.78; p = 0.02). Blood pressure control remained low (25.9% vs. 22.3%; PR 0.91; p = 0.06) and worsened in men (PR 0.83; p = 0.01). In conclusion, hypertension prevalence, awareness, and control did not significantly improve post-pandemic. More aggressive public health efforts are needed to reduce the adverse impacts of hypertension in the United States.
No takes yet. Share an insight, caveat, or question.
Essa et al. (2025) conducted a cross-sectional in Hypertension (n=14,449). Post-COVID-19 pandemic period (August 2021–August 2023) vs. Pre-COVID-19 pandemic period (2017–March 2020) was evaluated on Hypertension prevalence (PR 0.96, 95% CI 0.90-1.02, p=0.15). The prevalence of hypertension among US adults remained unchanged after the COVID-19 pandemic compared to the pre-pandemic period.
Synapse has enriched 10 related papers. Consider them for comparative context: